Holen Sie sich die Stockscreener-App
0.022
17.91%
-0.0048
Schlusskurs vom Vortag:
$0.0268
Offen:
$0.0214
24-Stunden-Volumen:
52,518
Relative Volume:
12.59
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
$-43.29M
KGV:
-0.02
EPS:
-1.1
Netto-Cashflow:
$-34.80M
1W Leistung:
-86.50%
1M Leistung:
-94.35%
6M Leistung:
-97.62%
1J Leistung:
-98.31%
1-Tages-Spanne:
$0.0214
$0.0269
1-Wochen-Bereich:
$0.0214
$0.0269
52-Wochen-Spanne:
$0.0214
$0.0269
Viracta Therapeutics Inc Stock (VIRX) Company Profile
Firmenname
Viracta Therapeutics Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie VIRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VIRX
Viracta Therapeutics Inc
|
0.022 | 0 | 0 | -43.29M | -34.80M | -1.10 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
555.11 | 33.86B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 30.51B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.51 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Viracta Therapeutics Inc Stock (VIRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-16 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2022-02-01 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-05-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-04-26 | Eingeleitet | SVB Leerink | Outperform |
| 2021-03-25 | Eingeleitet | Evercore ISI | Outperform |
Viracta Therapeutics Inc Aktie (VIRX) Neueste Nachrichten
Layoff Tracker: BioAtla Streamlines Operations By Cutting 30% of Staff - BioSpace
Viracta Therapeutics (VIRX) to Release Quarterly Earnings on Thursday - Defense World
Calif. biotech company once worth $476M lays off every remaining employee - MSN
Viracta Therapeutics, Inc. (NASDAQ:VIRX) Sees Significant Decrease in Short Interest - Defense World
Semler Scientific (SMLR) Projected to Post Earnings on Tuesday - Defense World
Viracta Therapeutics to cease operations and seek alternatives - MSN
Finance Watch: Third Harmonic, Q32 Bio Cut Jobs To Focus On Lead Assets - insights.citeline.com
Procaps Group (NASDAQ:PROC) vs. Viracta Therapeutics (NASDAQ:VIRX) Financial Comparison - Defense World
🔬 Latest pharma industry updates 👇 - substack.com
VIRX stock plunges to 52-week low, touches $0.08 - MSN
Viracta Therapeutics Terminates Employees & Winds Down Operations - Contract Pharma
Fierce Biotech Layoff Tracker 2025: Viracta shuts down; Layoffs hit Frontier - Fierce Biotech
Viracta Winds Down Business, Unable to Weather Financial Troubles - BioSpace
Viracta Therapeutics Announces Wind Down of Operations - GlobeNewswire
Viracta Therapeutics to cease operations and seek alternatives By Investing.com - Investing.com South Africa
Viracta Therapeutics Announces Wind Down Of Operations -February 05, 2025 at 06:39 pm EST - Marketscreener.com
Viracta Therapeutics hits end of the line, laying off all workers and winding down - Fierce Biotech
Viracta Therapeutics Announces Wind-Down and Leadership Changes - TipRanks
Viracta Therapeutics Winds Down Operations, Terminates Employees - MarketWatch
Leerink Partners slashes price target on Viracta Therapeutics Inc [VIRX] – find out why. - The DBT News
Views of Wall Street’s Leading Experts on Viracta Therapeutics Inc - SETE News
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
VIRX’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle
Analyzing VIRX’s price-to-book ratio for the last quarter - US Post News
Viracta Therapeutics to be delisted from Nasdaq - MSN
Pre-market Movers: SLGL, VIRX, ANVS, CUTR... - RTTNews
Why Triumph Group Shares Are Trading Higher By Over 36%; Here Are 20 Stocks Moving Premarket - Benzinga
Finanzdaten der Viracta Therapeutics Inc-Aktie (VIRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.01%
Kapitalisierung:
|
Volumen (24h):